Press release
Periodontal Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Vaxcyte, AngioLab, Inc., Cortexyme, Noveome Biotherapeutics
The Periodontal Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
"Periodontal Disease Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/periodontal-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Periodontal Disease Market.
Some of the key takeaways from the Periodontal Disease Pipeline Report:
* Companies across the globe are diligently working toward developing novel Periodontal Disease treatment therapies with a considerable amount of success over the years. Periodontal Disease Key players such as - Vaxcyte, AngioLab, Inc., Cortexyme, Noveome Biotherapeutics, Amyndas Pharmaceuticals, D and D Pharmatech, and others, are developing therapies for the Periodontal Disease treatment
* Periodontal Disease Emerging therapies such as - VAX PG, AL102-PDT, COR-588, ST266, AMY-101, P4M01, and others are expected to have a significant impact on the Periodontal Disease market in the coming years.
Periodontal Disease Overview
Periodontal diseases are mainly the result of infections and inflammation of the gums and bone that surround and support the teeth. In its early stage, called gingivitis, the gums can become swollen and red, and they may bleed. In its more serious form, called periodontitis, the gums can pull away from the tooth, bone can be lost, and the teeth may loosen or even fall out. Periodontal disease is mostly seen in adults. Periodontal disease and tooth decay are the two biggest threats to dental health.
Get a Free Sample PDF Report to know more about Periodontal Disease Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/periodontal-disease-pipeline-insight [https://www.delveinsight.com/report-store/periodontal-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Periodontal Disease Pipeline Therapeutics Assessment
* Periodontal Disease Assessment by Product Type
* Periodontal Disease By Stage and Product Type
* Periodontal Disease Assessment by Route of Administration
* Periodontal Disease By Stage and Route of Administration
* Periodontal Disease Assessment by Molecule Type
* Periodontal Disease by Stage and Molecule Type
DelveInsight's Periodontal Disease Report covers around products under different phases of clinical development like
* Late-stage products (Phase III)
* Mid-stage products (Phase II)
* Early-stage product (Phase I)
* Pre-clinical and Discovery stage candidates
* Discontinued & Inactive candidates
* Route of Administration
Some of the key companies in the Periodontal Disease Therapeutics Market include:
Key companies developing therapies for Periodontal Disease are - Amyndas Pharmaceuticals, 3M, AMD Lasers, Inc., ASA Dental S.p.A, Biolase, Inc., Carl Martin GmbH, Danaher, Dentsply Sirona, Deppeler SA, Karl Schumacher, Medtronic, Novartis AG, Pfizer, Inc., Planmeca Oy, Steris-Hu-Friedy, and Straumann AG., and others.
Download Sample PDF Report to know more about Periodontal Disease drugs and therapies [https://www.delveinsight.com/sample-request/periodontal-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Emerging Periodontal Disease Drugs Under Different Phases of Clinical Development Include:
* VAX PG: Vaxcyte
* AL102-PDT: AngioLab, Inc.
* COR-588: Cortexyme
* ST266: Noveome Biotherapeutics
* AMY-101: Amyndas Pharmaceuticals
* P4M01: D and D Pharmatech
Periodontal Disease Pipeline Analysis:
The Periodontal Disease pipeline report provides insights into
* The report provides detailed insights about companies that are developing therapies for the treatment of Periodontal Disease with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Periodontal Disease Treatment.
* Periodontal Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Periodontal Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Periodontal Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Periodontal Disease product details are provided in the report. Download the Periodontal Disease pipeline report to learn more about the emerging Periodontal Disease therapies [https://www.delveinsight.com/sample-request/periodontal-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Periodontal Disease Pipeline Market Drivers
* Growing awareness about oral hygiene
* Rising geriatric population across the world
Periodontal Disease Pipeline Market Barriers
* Growing awareness about oral hygiene
* Rising geriatric population across the world
Scope of Periodontal Disease Pipeline Drug Insight
* Coverage: Global
* Key Periodontal Disease Companies: Vaxcyte, AngioLab, Inc., Cortexyme, Noveome Biotherapeutics, Amyndas Pharmaceuticals, D and D Pharmatech, and others
* Key Periodontal Disease Therapies: VAX PG, AL102-PDT, COR-588, ST266, AMY-101, P4M01, and others
* Periodontal Disease Therapeutic Assessment: Periodontal Disease current marketed and Periodontal Disease emerging therapies
* Periodontal Disease Market Dynamics: Periodontal Disease market drivers and Periodontal Disease market barriers
Request for Sample PDF Report for Periodontal Disease Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/periodontal-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1
Periodontal Disease Report Introduction
2
Periodontal Disease Executive Summary
3
Periodontal Disease Overview
4
Periodontal Disease- Analytical Perspective In-depth Commercial Assessment
5
Periodontal Disease Pipeline Therapeutics
6
Periodontal Disease Late Stage Products (Phase II/III)
7
Periodontal Disease Mid Stage Products (Phase II)
8
Periodontal Disease Early Stage Products (Phase I)
9
Periodontal Disease Preclinical Stage Products
10
Periodontal Disease Therapeutics Assessment
11
Periodontal Disease Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Periodontal Disease Key Companies
14
Periodontal Disease Key Products
15
Periodontal Disease Unmet Needs
16
Periodontal Disease Market Drivers and Barriers
17
Periodontal Disease Future Perspectives and Conclusion
18
Periodontal Disease Analyst Views
19
Appendix
20
About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=periodontal-disease-pipeline-drugs-analysis-report-2024-updates-fda-approvals-clinical-trials-therapies-moa-roa-by-delveinsight-vaxcyte-angiolab-inc-cortexyme-noveome-biotherapeutics]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Periodontal Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Vaxcyte, AngioLab, Inc., Cortexyme, Noveome Biotherapeutics here
News-ID: 3445650 • Views: …
More Releases from ABNewswire
Understanding Magnetic Switches: Types, Working Principles, and Applications
A magnetic switch is a versatile electrical device that operates by responding to magnetic fields. From Hall Effect to reed switches, explore their functions, types, and diverse applications.
What is a Magnetic Switch?
A magnetic switch is an electrical device that operates by responding to the presence of a magnetic field. It functions by closing or opening its contacts based on the strength of the magnetic field. Specifically, the switch remains closed…
Innovating embedded downlight technology: Leading the global trend of intelligen …
The strong rise of China's manufacturing industry has profoundly reshaped the technological landscape and development trajectory of embedded downlights. With its unparalleled industrial chain advantages, continuous technological innovation, and significant cost-effectiveness, Chinese enterprises have risen from participants in the global lighting industry to undisputed leaders. This transformation goes far beyond the huge production scale; it lies in the thorough innovation of the core technical content and application boundaries of embedded…
North China Electric Power University Foreign Aid Training Program Visits Yiyuan …
On July 23, 2025, the Electrical Industry Training Program of North China Electric Power University's Foreign Aid Project visited Yiyuan Technology for an exchange visit. The purpose was to gain in-depth insights into the company's innovations in renewable energy technology promotion and application [https://www.yiyen.com/about/], and to build bridges connecting university-enterprise cooperation with foreign aid initiatives.
Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-1.jpg
Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-3.jpg
Upon arrival, the delegation received a warm welcome from company leadership and the reception…
Pure Sine Wave Low Frequency Inverter Charger
Pure sine wave low frequency inverter [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] is widely used and suitable for a variety of scenarios. In terms of home backup power, it can provide reliable power during power outages, ensuring that essential appliances such as refrigerators, air conditioners and medical equipment continue to operate . For solar power generation systems, Inverter charger [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] can converter DC Power from Battery, which charged by solar panels, into clean alternating current…
More Releases for Periodontal
Surge In Dental Tourism Fuels Growth In The Periodontal Market: A Key Catalyst A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Periodontal Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The scale of the periodontal market has rapidly expanded lately. Its expansion is predicted to climb from $11.78 billion in 2024 to $13.08 billion in 2025, showcasing a compound annual growth rate (CAGR) of 11.0%. Factors…
Periodontal Market Size, Industry Share, Trends - 2033
The new report published by The Business Research Company, titled "" Periodontal Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the periodontal market size has grown rapidly in recent years. It will grow from $10.55 billion in 2023…
Periodontal Therapeutics Market in 2023: Emerging Trends, Treatment Innovations, …
The latest research study released by Transparency Market Research on "Periodontal Therapeutics Market Forecast to 2019-2027 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Periodontal Therapeutics industry, as well as predicted…
Periodontal Therapeutics Market - Enhancing Quality of Life through Comprehensiv …
Newark, New Castle, USA - new report, titled Periodontal Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Periodontal Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Periodontal Therapeutics market. The report offers an overview of the market, which…
Periodontal Inflammation/ Periodontal Disease Market to Witness Growth by 2032, …
DelveInsight's "Periodontal Inflammation/ Periodontal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Periodontal Inflammation/ Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Inflammation/ Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Periodontal Inflammation/ Periodontal Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Periodontal Disease - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Periodontal Disease - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Periodontal disease is also called as gum disease. It is a set of infections and inflammatory condition affecting the tissue of the gum and the bones that surround and support the teeth.
They are two types of…
